Angelini Pharma keeps investing in research and innovation and announces its contribution to Argobio, a French start-up incubator dedicated to life sciences.
Work, relationships and healthcare are the three biggest obstacles facing epilepsy sufferers. Here's why we need to focus on them
Interview with Agata Szulc, head of the Department of Psychiatry at the Medical University of Warsaw
With this aim, Angelini has acquired Arvelle Therapeutics
YouTube star with over 6 million subscribers, Dan Howell is ambassador for the charity Young Minds and his next goal is to remove the stigma from discussing mental health
High-pressure life sometimes makes youngsters retreat from the world. It’s a growing phenomenon of young people withdrawing into themselves to escape the stresses of society
As the winter nights draw in, more and more of us will be curling up on the sofa with a horror film. But can scary movies have negative effects on our mental health?
Agnese Cattaneo, Chief Medical Officer Angelini Pharma, talks about a recent research on the awareness about mental health and the impact of the pandemic.
According to the UN, cases grew by 20% globally during the most challenging months of the pandemic. We discuss the situation with Marcella Pirrone, president of the European Wave network, and with Concetta Schiavone, psychologist in a women's shelter in Southern Italy
A disease awareness campaign promoted by Angelini Pharma
"We, as members of the society, have a responsibility to bring awareness of the needs of people suffering from mental health disorders" says Olga Insua, general manager Angelini Pharma Spain.